Development of the renal glucose reabsorption inhibitors: a new mechanism for the pharmacotherapy of diabetes mellitus type 2

J Med Chem. 2009 Apr 9;52(7):1785-94. doi: 10.1021/jm8013019.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Clinical Trials as Topic
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Drug Evaluation, Preclinical
  • Glucose / metabolism*
  • Glucosides / chemistry
  • Glucosides / pharmacology
  • Glucosides / therapeutic use
  • Humans
  • Hypoglycemic Agents / chemistry
  • Hypoglycemic Agents / pharmacology
  • Hypoglycemic Agents / therapeutic use*
  • Kidney / metabolism*
  • Sodium-Glucose Transporter 2 Inhibitors*

Substances

  • Glucosides
  • Hypoglycemic Agents
  • Sodium-Glucose Transporter 2 Inhibitors
  • Glucose